Short answer
RECURSION PHARMACEUTICALS, INC. (RXRX) filed an 8-K current report with the SEC on June 18, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected Najat Khan and Franziska Michor as Class II directors through the 2029 annual meeting.
RECURSION PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected Najat Khan and Franziska Michor as Class II directors through the 2029 annual meeting
- Director votes included 126,675,762 broker non-votes, limiting participation in contested governance matters
- Executive compensation advisory vote approved, with 206,171,008 for and 30,893,147 against
- PricewaterhouseCoopers LLP ratified as independent auditor for 2026, with 361,743,500 votes in favor
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other RECURSION PHARMACEUTICALS, INC. 8-K filings
Get the next RXRX 8-K as it lands
Follow RXRX for push alerts, or ask the research agent what this filing means.